retinal pigment endothelium

For the first time, a transplant of replacement tissue grown from stem cells has been shown to be feasible for patients with macular degeneration.

Vision researcher John Dowling has spent a lifetime studying the neural architecture of the retina. He is closing his laboratory after 53 years, opting to extend these studies as a postdoc.

Preliminary data from human embryonic stem cell trials for two degenerative eye disorders are promising, but challenges remain for more complex tissues.

Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.